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Abstract In several studies, different antigenic preparations
and diverse immunological tests were applied for
serodiagnosis of Fasciola hepatica infections. Most of these
preparations showed cross-reactivity with proteins of other
parasites. Application of purified antigens might reduce these
cross-reactivities. Here, we used fast protein liquid chroma-
tography (FPLC)-fractionated extracts of F. hepatica
excretory/secretory antigens (E/S Ags) for serodiagnosis of
human and sheep fasciolosis. To develop an improved diag-
nostic method, we fractionated F. hepatica E/S Ags by anion
exchange chromatography on a Sepharose CL-6B column and
then tested the serodiagnostic values of the fractions. We used
sera from F. hepatica-infected human and sheep as positive
controls. Sera from patients with hydatidosis and strongyloi-
diasis were used for cross-reactivity studies. Enzyme-linked
immunosorbent assays (ELISA) of the second FPLC peak,
containing 20, 25, and 70 kDa proteins, discriminated be-
tween F. hepatica-infected and uninfected human and sheep
samples. Fractionation of F. hepatica E/S Ags by FPLC is a
fast and reproducible way of obtaining antigens useful for
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serodiagnosis of human and sheep fasciolosis with acceptable
sensitivity and specificity.
Keywords Fasciolosis . Fast protein liquid chromatography .
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Introduction
Fasciolosis is a cosmopolitan parasitic disease caused by
Fasciola hepatica. This infection occurs in a variety of mam-
mals, including humans. It is highly prevalent in sheep due to
their close contact with infective pasture. This parasite com-
monly inhabits the hepato-biliary system of the affected hosts
(Mas-Coma et al. 2005). Annual economic loss caused by the
disease in domestic animals was estimated to be US $2 billion,
mainly due to condemned livers, reduced milk yields, fertility
disorders, and diminished meat production (Spithill et al.
1999). During the past two decades, the disease has emerged
as a serious problem in veterinary medicine and human health.
In 1999, over 10,000 human cases were reported in Gilan,
the Northern Province of Iran (Rokni et al. 2002). Sporadic
cases have also been reported in other provinces including
Kurdistan, Zanjan, Mazandaran, Tehran, and Azarbaijan
(Mohamed et al. 2004). Prevalence of the infection in domes-
tic animals has been reported from 1.07 % to more than 50 %
in different areas of Iran (Rokni et al. 2010).
Human fasciolosis is commonly diagnosed by detection of
parasite eggs in stool, but this method is not reliable and has
poor sensitivity in diagnosis during the acute ectopic stage.
Recently, immunodiagnostic methods, including enzyme-
linked immunosorbent assays (ELISA), have been widely ap-
plied in parasitic diagnoses (Hillyer 1999). In several studies,
different antigenic preparations and diverse immunological
tests were used for serodiagnosis of F. hepatica infections.
The excretory/secretory antigens (E/S Ags), as well as some
somatic and metabolic products (enzymes, fatty acid-binding
proteins, etc.) of this parasite, exhibit immunogenic properties
and could trigger humoral immune responses. Unfortunately,
most of them cross-react with antigens of other parasites. We
proposed that application of purified antigens might reduce
this cross-reactivity. In this study, fast protein liquid chroma-
tography (FPLC)-fractionated extracts of F. hepatica E/S Ags
were applied for serodiagnosis of fasciolosis and their speci-
ficity and sensitivity were evaluated.
Materials and methods
Parasite and serum samples
Livers from F. hepatica-infected sheep were collected from
the Kahrizak slaughterhouse located in Tehran, Iran. Adult
live flukes were removed from the infected livers, washed
six times with warm sterile phosphate-buffered saline (PBS),
and used to prepare total extract and E/S Ags.
Sera from 14 fasciolosis human patients, whose infections
were confirmed in a medical laboratory using a commercial
ELISA kit (Pishtaz Teb, Iran) and routine stool exams, and
from 20 healthy people who had no evidence of intestinal
parasite infections and negative stool exams were used as
positive and negative human samples, respectively.
In addition, sera from 12 infected sheep, in which
fasciolosis was obvious during examination of the liver
at the slaughterhouse, and from 13 healthy animals were
applied as positive and negative animal samples for the
development of the immunoassays. To determine the
cross-reactivity of the antibodies from different parasite
infections, we applied four strongyloidiasis and four
hydatidosis patients’ sera in the study. Moreover, to as-
sess the cross-reactivity of infected sheep sera with other
parasitic diseases, we used sera from sheep infected with
Echinococcus granulosus, Dicrocoelium dendriticum, and
Taenia hydatigena in the experiments.
Preparation of F. hepatica antigens
Preparation of F. hepatica E/S antigens
After washing the flukes with PBS, the parasites were incu-
bated in RPMI-1640 medium (1 fluke per 2 ml of medium;
Gibco-BRL, Gaithersburg, MD, USA), containing 100 IU/ml
of penicillin, 100 μg/ml of streptomycin, and 1X anti-protease
cocktail at 37 °C for 24 h in a 5 % CO2 incubator as described
elsewhere (Spithill et al. 1999). The supernatant, containing
the E/S product of the parasites, was collected and centrifuged
at 10,000×g for 30 min at 4 °C. Afterwards, the clear super-
natant was concentrated via ultrafiltration using 4 kDa mem-
brane filters (Eppendorf, Germany). The protein concentration
of the supernatant was estimated using the Bradford method
with bovine serum albumin (BSA) as the standard, and the
product was stored at −20 °C.
Preparation of F. hepatica somatic antigens
Adult flukes were washed six times in PBS, pH 7.3, to remove
debris. One gram of the flukes was added to 3 ml of lysis
buffer (50 mM Tris pH 8.0 containing 2 mM EDTA, 2 mM
2-ME, 100 mM NaCl, 5 % glycerol, and 1X anti-protease
cocktail) and homogenized with an electrical homoge-
nizer (IKA®T25 digital ULTRA-TURRAX, Germany).
The homogenate was centrifuged at 13,000×g for
30 min. The supernatant containing soluble products
was removed and stored at −20 °C.
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SDS-PAGE of F. hepatica proteins
F. hepatica E/S and somatic antigens were separated by
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) under reducing conditions. Briefly, 10 μg of each
extract were loaded onto a 4 % stacking and 15 % separating
gel. After electrophoresis, the protein bands were visualized
with Coomassie blue G-250 staining and their apparent molec-
ular weights were determined by comparing with wide molec-
ular weight protein marker (Sinaclon, Tehran, Iran).
FPLC fractionation and silver nitrate staining of the E/S
antigen
The E/S antigen was fractionated by anion exchange chroma-
tography using an AKTA PRIME Plus FPLC system (GE
Healthcare Biosciences, Uppsala, Sweden). The concentrated
E/S Ags were dialyzed against 20 mM Tris–HCl pH 8.0.
Then, 3 mg of the E/S Ags was applied onto a DEAE-
Sepharose CL-6B resin column and eluted with 20 mM
Tris–HCl pH 8.0 containing 1MNaCl. The sample was eluted
at a flow rate of 1 ml/min. Elution was monitored by measur-
ing at 280 nm. Similar peaks from several runs were pooled
and concentrated by lyophilization. The lyophilized fractions
were resuspended in 1 ml of distilled water and separated by
15 % SDS-PAGE. Proteins were stained with silver nitrate,
and their apparent molecular weights were compared with the
E/S Ag pattern.
Western blotting
We studied the immunoreactivity of F. hepatica E/S Ags and
the contents of the fractions by Western blotting. Proteins
were transferred to polyvinylidene difluoride (PVDF) mem-
brane (Millipore, Bedford, USA) for 90 min at 0.7 mA/cm2
using a semi-dry transfer apparatus (PeQlab). After the trans-
ferring step, the membrane was weakly stained for about 3–
5 min with 0.2 % Ponceau S (Sigma-Aldrich, UK). Then, the
membrane was dried and cut into 2-mm-wide stripes. After
destaining with distilled water, the strips were washed and
blocked with 2 % BSA overnight at 4 °C and then 1:100
diluted human or 1:500 diluted ovine sera were added at room
temperature (RT) for 2 h on a rocker. The strips were then
washed three times with PBS containing 0.05 % Tween 20
(PBS-T) for 10 min and incubated either with horseradish
peroxidase (HRP)-conjugated polyclonal anti-human anti-
body (Sigma-Aldrich, Germany) diluted 1:1000 in BSA for
60 min at RT or HRP-conjugated polyclonal rabbit anti-
sheep antibody (Sina Biotech, Iran) diluted 1:5000 and
incubated as above. The strips were washed and incubated
with chemiluminescent substrate (Luminol and H2O2) for
2 min at RT. Finally, the reactive bands were detected on
X-ray film within 10–20 s under safelight conditions as
previously described (Falak et al. 2013).
ELISA
The IgG reactivity of total E/S Ags and FPLC fractions were
determined by an indirect ELISA as described by Morales
et al. with some modifications (Morales and Espino 2012).
To identify the optimal dilutions of antigen and antibody in
ELISA, a checker board titration assay was carried out prior to
the final experiments. Briefly, wells of Polysorb micro titra-
tion plates (Nunk, USA) received 50μl of 2μg/well E/S Ag or
2 μg/well of fractionated proteins in 0.1 M bicarbonate buffer
pH 9.6 and incubated overnight at 4 °C. After washing with
PBS-T, wells were blocked with 250 μl of 2 % BSA/well and
the plates were incubated for 90 min at 37 °C. Following a
brief washing, 50μl of 1:100 diluted patients’ or 1:500 diluted
ovine sera were added and the plates were incubated for 2 h at
37 °C. Plates were then washed six times with PBS-T and
received 50 μl/well of 1:1000 diluted HRP-conjugated poly-
clonal anti-human IgG or 1:5000 diluted HRP-conjugated
polyclonal rabbit anti-sheep antibody, respectively, and incu-
bated for 60 min at 37 °C. The plates were then washed four
times, and 50 μl of tetramethylbenzidine (TMB)/H2O2 mix-
ture was added as the chromogen/substrate solution.
Following 15 min incubation in the dark at RT, the enzymatic
reaction was stopped by adding 50 μl of 2 N sulfuric acid, and
the optical density (OD) was measured at 450 nm using an
ELISA micro-plate reader (BioHit BP 800, Finland).
Mass spectrometry and database search
Following anion exchange chromatography, the purified frac-
tions were subjected to SDS-PAGE for second purification
step based on molecular weights and the resolved protein
bands were visualized by colloidal Coomassie blue staining.
After mild destaining in distilled water, the immunoreactive
bands were manually excised from the gel and analyzed by
matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF/MS) at Yurk Company, England.
Mass spectrometry was performed using an ABI 4800
MALDI-TOF/TOF analyzer (Applied Biosystems, Foster
City, CA, USA). Mass spectra were recorded in reflector-
positive mode with a scanning range of 900–4000 Da. Five
monoisotopic precursors from each purified fraction with
signal/noise (S/N) ratios greater than 200 were selected for
MS/MS analysis. The Swiss-Prot and NCBI databases for
the peptide mass maps were searched using the Mascot search
engine (Matrix-Science, London, UK). Searches were done
with tryptic specificity allowing one missed cleavage and a
tolerance on the mass measurement of 100 ppm in MS mode
and 0.5 Da for MS-MS ions. Oxidation and carbamidometh-
ylation of the cysteines were also selected as the fixed possible
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modification of fragmented peptides. A protein identification
was considered accurate when at least three peptides were
identified with an overall Mascot score greater than 60.
Data analysis
Statistical analyses were performed using the Student’s t or
Mann–Whitney tests using SPSS version 20. The ELISAs
were performed in duplicate, and the results were expressed
as the mean absorbance value (A450) for each determination.
The mean A450 plus 3 standard deviations (SD) of the
negative control group was used as the cutoff limit be-
tween positivity and negativity status for fasciolosis.
The diagnostic sensitivity and specificity were calculat-
ed by common statistical methods as described else-
where (Morales and Espino 2012).
Results
SDS-PAGE
The somatic and E/S products of F. hepatica were separated
by SDS-PAGE under reducing conditions. The electrophoretic
patterns of the extracts were similar, with protein bands rang-
ing from 4 to 100 kDa (Fig. 1); however, the intensities of the
bands differed. The somatic extract contained proteins with
apparent molecular weights of 12–14, 25, 33–39, and 48–
70 kDa, while the more intense bands of the E/S product were
located at 20–27 and 40–48 kDa. Less intense bands were
observed at 15–20, 65, and 75–100 kDa.
Analysis of the FPLC fractions
Two major protein peaks were observed following anion
exchange chromatography of F. hepatica E/S Ags (Fig. 2).
The fractions corresponding to these peaks were collected
and referred to as P1 and P2. The contents of both peaks
were lyophilized and subjected to SDS-PAGE and silver
nitrate staining (Fig. 3a). P1 and P2 eluted at 65 and
75 % NaCl concentrations, respectively.
On Western blots, sera from fasciolosis patients
reacted with proteins of 12, 19, 48, and 70 kDa in the
20th elute (P1) and, 20, 25, 63, and 70 kDa in the 24th
elute (P2). The strongest immunoreactivity was seen
with the 25-, 63-, and 75-kDa proteins, while faint
bands were seen at 12 and 14 kDa (Fig. 3b). Similar
results were seen with ovine sera, with bands at 14, 17,
and 48 kDa from P1 and 18 and 20 kDa from P2.
Overall, the major immunogenic protein bands were ob-
served at approximately 12–14, 20, 25, 35, 40, 48, and
75 kDa (Fig. 3c).
Immunoblotting of E/S Ags with human and sheep sera
Sera from both humans and sheep with chronic fasciolosis
reacted with proteins of 12, 14, 20, 25, 27, 35, 40, and
70 kDa (Fig. 4). The highest prevalence of immunoreactivity
of human and sheep sera was with proteins of 11–15 kDa
(41.17 %), 35 kDa (35.2 %), 25 kDa (23.5 %), and 27 kDa
(29.4 %) (Table 1).
Pooled sera of strongyloidiasis and hydatidosis patients
were used to assess cross-reactivity. Strongyloidiasis patients’
sera reacted with some F. hepatica proteins, including the 63-
kDa protein, while hydatidosis patients’ sera reacted strongly
with F. hepatica 17, 48, and 50 kDa proteins.
Fig. 1 SDS-PAGE of F. hepatica somatic and excretory-secretory
antigens. F. hepatica somatic (lanes 1 and 2) and E/S Ags (lanes 3
and 4) were separated on 15 % polyacrylamide gels and stained with
brilliant Coomassie blue G-250. MW protein molecular weight
marker (Sinaclon, Iran)
Fig. 2 Anion exchange chromatography of F. hepatica E/S Ags. FPLC
chromatogram of F. hepatica E/S Ags obtained by anion exchange
chromatography on a DEAE-Sepharose CL-6B column. Two typical
peaks (P1, P2) were obtained when the NaCl in the elution buffer
exceeded 60–70 %
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To focus on the specific immunogens of F. hepatica, we
omitted the cross-reactive antigens from the study. The pro-
teins that reacted only with infected human and ovine sera
were examined to identify possible protein families and amino
acid sequences.
Mass spectrometry and database search
The main immunoreactive bands were excised from the gel
and identified by mass spectrometry. The MALDI-TOF anal-
ysis identified aldolase, glutathione S-transferase (GST), fatty
acid-binding protein (FABP), enolase, and cathepsin L1 (CL1)
as the major seroreactive components of the F. hepatica E/S
Ags in human and sheep chronic fasciolosis (Table 2).
Detection of the immunoreactivity of F. hepatica E/S Ags
by human sera
The mean OD±3SD values achieved for E/S Ags from
positive and negative control groups were 1.48 ± 0.39
and 0.27 ± 0.05 (Fig. 5). The ODs of the positive con-
trols were significantly higher than those of the negative
controls (P< 0.0001). Mean ODs of strongyloidiasis and
hydatidosis sera were 0.71 ± 0.31 and 0.72 ± 0.39,
respectively.
When the wells were coated with P1, the mean ODs
for positive controls were 1.2 ± 0.42 (Fig. 6). The ODs
of strongyloidiasis and hydatidosis sera with this frac-
tion were 0.68 ± 0.3 and 0.9 ± 0.42, respectively.
When the wells were coated with P2, the mean ODs
for positive controls were 0.9 ± 0.3. However, this frac-
tion did not strongly cross-react with strongyloidiasis or
hydatidosis sera (Fig. 7).
Immunoreactivity of sheep sera with F. hepatica E/S Ags
Evaluation of the immunoreactivity of F. hepatica total E/S
Ag with ovine sera showed a significant difference be-
tween mean ODs of the infected animals (1.93 ± 0.13)
and the healthy controls (0.5 ± 0.11). When wells were
Fig. 3 SDS-PAGE of FPLC-purified fractions of F. hepatica E/S Ags. a
Fractions 18–24 were electrophoresed on 15 % polyacrylamide gels
and visualized by silver nitrate staining. The lane numbers 20 and
24 contain the main protein bands and correspond to peaks 1 and 2,
respectively. b, c Immunoblotting of fractionated proteins with
infected human and sheep sera, respectively
Fig. 4 Immunoblotting of F. hepatica E/S Ags with human and ovine
sera. a From left to right, the strips refer to protein molecular weight
marker. Immunoblotting of E/S Ags with sera from negative controls
(pooled sera): 1–5 fasciolosis patients, 6–7 strongyloidiasis patients,
and 8–9 hydatidosis patients, respectively. b From left to right, the
strips refer to protein molecular weight marker: 1–12 immunoblotting
with sera from F. hepatica-infected ovine and pooled sera from negative
controls, respectively
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coated with E/S Ags, P1, and P2, the mean ODs with
infected sheep sera were 1.93 ± 0.13, 1.80 ± 0.137, and
1.61 ± 0.21, respectively, while ODs with healthy sheep
sera were 0.42 ± 0.07, 0.36 ± 0.04, and 0.26 ± 0.04, re-
spectively. The mean OD values with total E/S Ags,
P1, and P2 using sheep sera with other similar parasitic
diseases were 0.66, 0.47, and 0.34, respectively. Overall,
these results, similar to results obtained with human
sera, showed that there is significant difference between
mean OD of the patients sera with of 24th fraction
compared to healthy controls, while the total E/S Ags
and the P1 fraction showed a higher OD with endemic
parasites.
Discussion
We found that the somatic and E/S products of F. hepatica
share several identical molecules, including the 15–25- and
48-kDa proteins. These results agree with the reports of
Meshgi et al. (2008) and Upadhyay and Kumar (2002).
Based on blotting results, we found that the specific immuno-
genic protein bands of the E/S product were 20–27 and 40–
48 kDa molecules. Moreover, 12–14, 25, 33–39, and 48–
70 kDa proteins comprised the main somatic immunogens
of F. hepatica. Allam et al. (2002) showed that some low
molecular weight proteins of the whole parasite extract, rang-
ing from 25 to 48 kDa, comprise the main antigenic molecules
Table 1 Immunoreactive protein
bands found via immunoblotting
of Fasciola hepatica antigens
with human and sheep sera
Sample ID Immunogenic proteins of
F. hepatica to human sera
Immunogenic proteins of
F. hepatica to sheep sera
1 12 35, 48
2 12 48, 60
3 35, 48, 65–70 14, 25
4 27,40 11–15, 17, 19
5 14, 17, 19, 25–27, 35 11–14
6 63 60
7 – 40, 63
8 – 11–15, 30, 35, 65, 75
9 17, 48, 50 14, 27, 40–48, 63, 70–75
10 – 15, 25–27, 40, 48
11 – 11–15, 17–20, 25, 27–35, 40
12 – 11–15, 17, 19, 27, 30, 35–40, 50–63
Table 2 Mass spectrometry results for fractionated proteins of Fasciola hepatica
Protein fraction Protein name/species Nominal mass
(Mr)/PI
Protein
score
Accession
key
Observed
mass
Peptide sequence
Unknown 12 kDa
immunogen
Fatty acid-binding protein
type 2
Fatty acid-binding protein
Fh15
14,926/5.93
14,760/5.91
187
172
gi|124012088
gi|47115698
1681.8058
2184.9514
1441.6479
1821.9578
35RNEKPEFTFELEGNKM48
61KTTTFTFGEEFKDETFDNRT78
10KYGHSENMEAYLKK21
33KILNAKPEFTFTLEGNKM48
Unknown 14 kDa
immunogen
Hemoglobin F2
Fatty acid-binding protein
type 3
16,681/7.03
14,671/9.02
75
72
gi|159461074
gi|47116941
1307.7157
2264.0508
108KDQFTGAAPIFIKF119
59KTTVISFTFGEEFKEETADGRT78
Unknown 25 kDa
immunogen
Chain A, Fasciola hepatica
Sigma Class Gst
Mu-glutathione transferase,
partial [Fasciola hepatica]
24,690/8.86
24,592/5.88
116
66
gi|292659520
gi|159058
1778.8253
1306.6948
84KMMGETDEEYYLIERI97
84RISMIEGAAMDLRI95
Unknown 36 kDa
immunogen
Cathepsin L-like
[Fasciola hepatica]
35,611/5.79 345 gi|137740802 2321.9717
1768.8569
1191.5632
170KQFGLETESSYPYTAVEGQCRY189
199KVTGYYTVHSGSEVELKN214
273KNSWGLSWGERG282
Unknown 39 kDa
immunogen
Fructose-bisphosphate
aldolase class I,
partial [Clonorchis
sinensis]
98,805/9.66 86 gi|358253990 2357.0938 622kGVVPLAGSLNECTTQGLDG
LAERC644
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of F. hepatica. These differences could be due to different
parasite isolates from different host species, geographic vari-
ations, or the different methods of protein extraction. E/S Ags
of F. hepatica contain several glycoproteins, including hemo-
globin and cysteine proteases, which are usually recognized as
immunogens by the host immune system (McGonigle and
Dalton 1995).
Based on potential antigenicity of the E/S product, its pu-
rified antigens were used in several immunoassays for
serodiagnosis of animal and human fasciolosis (Carnevale
et al. 2001; Cornelissen et al. 2001). We used the E/S product
and its purified proteins as the antigen source. Antigenic pro-
teins with apparent molecular weights of 12, 14, 19, 20,
25, 27, 35, 40, and 70 kDa reacted with both human
and sheep sera. None of these proteins cross-reacted
with Strongyloides stercoralis-infected patients’ sera,
which has the same geographical prevalence as
fasciolosis and hydatidosis, which are endemic zoonotic
parasite diseases in Iran. Our results agree with those of
Rokni et al. (2004), who found that the 14-kDa E/S
protein and the 27- and 29-kDa somatic extract proteins
are major immunogenic molecules. However, Gonenc
et al. found that the 33-, 39.5-, and 42-kDa proteins
are specific E/S Ag immunogens. In addition, they re-
ported a 63-kDa protein as a shared antigen present in
both the somatic and E/S products (Gonenc et al. 2004).
Our study showed that the 63-kDa protein is a major
cross-reactive protein in strongyloidiasis, while the 17-,
48-, and 50-kDa proteins cross-reacted with hydatidosis
patients’ sera. This is likely due to shared epitopes between
Fig. 5 Comparison of the immunoreactivity F. hepatica E/S Ags with
human sera by ELISA. Immunoreactivity of fasciolosis, strongyloidiasis,
and hydatidosis patients’ sera compared to healthy controls using
F. hepatica E/S Ag-coated ELISA plates. The dashed line represents the
cutoff point between seronegative and seropositive populations, which
was calculated as the mean plus 3 standard deviations of the healthy
population (mean+ 3SD)
Fig. 6 Comparison of the immunoreactivity of F. hepatica fraction 20
with human sera by ELISA. Optical densities of ELISAs using sera from
healthy controls, strongyloidiasis, and hydatidosis patients on fraction 20
(first peak) of anion exchange chromatography as the coating antigen.
The dashed line represents the cutoff point between seronegative and
seropositive populations, which was calculated as the mean plus 3
standard deviations of the seronegative population (mean+ 3SD)
Fig. 7 Comparison of the immunoreactivity of F. hepatica 24th fraction
with different groups of human sera by ELISA. Analysis of sera obtained
from healthy controls, strongyloidiasis, and hydatidosis patients by
ELISA using fraction 24 (second peak) of anion exchange
chromatography as the coating antigen. Dashed line represents the
cutoff point between seronegative and seropositive populations, which
was calculated as 3 standard deviations from the mean result of the
seronegative population (mean+ 3SD)
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E/S Ags of F. hepatica and S. stercoralis and E. granulosus
(Mohamed et al. 2004). Yamano et al. showed that the Gal-
beta1-6Gal sequence was a common carbohydrate epitope
between Echinococcus multilocularis and E. granulosus.
Cross-reactivity of this sequence with F. hepatica has been
reported in several studies. Furthermore, it was demon-
strated that Gal-beta1-6Gal is a common epitope of various
other parasites (Yamano et al. 2009).
We did not assay acute fasciolosis serum samples in this
study, but in other studies, 25–30 kDa proteins of E/S Ags
showed specificity in both acute and chronic phases of
fasciolosis in rabbits, cows, and sheep (Rivera-Marrero
et al. 1988). Sampaio-Silva et al. reported that 25–27 kDa
components of E/S products of adult flukes could recog-
nized by fasciolosis patients’ sera (Sampaio-Silva et al.
1996).
Our findings showed that the total E/S product is not a
specific preparation for serodiagnosis of human and sheep
fasciolosis by ELISA. This finding agrees with previous stud-
ies in cattle (Cornelissen et al. 1999; Bossaert et al. 2000),
other animals, and humans (Mezo et al. 2003; Demerdash et
al. 2011). Similar toWestern blotting experiments of Adelaida
et al., we observed no reactive protein bands in the negative
controls (Valero et al. 2012).
Fractionation of the E/S product by ion exchange chroma-
tography enabled us to partially purify the 17-, 20-, 25, and
70-kDa immunogenic proteins by sodium chloride gradient.
The purified proteins did not show cross-reactivity with en-
demic parasites.
Overall, FPLC fractions revealed more specific results
for serodiagnosis of human fasciolosis than those obtained
from somatic extracts or total E/S products. This finding is
also in line with previous reports (Ashrafi et al. 2006;
Rokni et al. 2010; Sarkari et al. 2012; Valero et al. 2012).
Coating of the ELISA plates with the second FPLC peak
containing the 17-, 20-, 25-, and 70-kDa proteins revealed
100 % sensitivity and specificity, similar to findings of
Mezo et al., who also used FPLC for protein fractionation
(Mezo et al. 2003). In the present study, the 27-kDa protein
was recognized by human and sheep sera. The lower mo-
lecular weight antigens were not found in other parasites. It
was predicted that CL1 could play a vital role in the adap-
tive immune response to F. hepatica infection (Mezo et al.
2003). Later, Farghaly et al. reported that the 27-kDa pro-
tein of the E/S product is 100 % sensitive and specific for
diagnosis of fasciolosis and could be nominated as the
most immune reactive protein (Farghaly et al. 2009). This
finding was determined by Falcon assay screening test
(FAST-ELISA) and immunoblotting. However, we found
protein bands with apparent molecular weights of 11–15,
25, 27, and approximately 35 kDa had prominent immu-
noreactivity in ovine and human fasciolosis, similar to oth-
er studies (Mezo et al. 2003; Hacariz et al. 2011; Morales
and Espino 2012). Fractionation of the E/S contents via
chromatography helped us further resolve the components
by SDS-PAGE and subsequent MS-MS analysis.
Our study identified GST, FABP, CL1, and aldolase as the
major immunoreactive components of the F. hepatica E/S
products. Notably, these proteins were recently found to be
highly abundant either on the surface or in internal organs of
F. hepatica (Robinson et al. 2009; Hacariz et al. 2011;Morales
and Espino 2012). Similar to Espino et al., in this study, dif-
ferent isoforms of F. hepatica FABP (type 2 and type 3) were
purified (Espino and Hillyer 2001). The abundance of FABP
on the surface of F. hepatica indicates that this protein plays
role as an antioxidant as well as a transporter of fatty acids
from the environment.
The purified 25 kDa protein was identified as GST,
an enzyme found in all animals with a confirmed role
in detoxification and removal of harmful molecules.
GST is permanently expressed on tegumental surfaces
of F. hepatica and is also excreted by the parasite.
The immunogenicity of GST was also previously dem-
onstrated (Abath and Werkhauser 1996).
Aldolase (39 kDa), an essential glycolytic enzyme in car-
bohydrate metabolism, is vital for energy production, activity,
and parasite survival (Espino and Hillyer 2001).
In summary, we demonstrated that F. hepatica fractions are
excellent antigens for serodiagnosis of human and sheep
fasciolosis. Western blotting showed that bands with MW of
11–15, 25–27, and 39 kDa are the most prominent and spe-
cific immunoreactive components of F. hepatica E/S Ags
representing FABP, GST, CL1, and aldolase, respectively.
Based on these results, it seems that combination of ELISA
and Western blotting with F. hepatica fractions could be ap-
plied for specific and sensitive diagnoses of human and sheep
fasciolosis. This study was carried out based on the analysis of
human and ovine fasciolosis sera, and it seems that the anti-
gens in the second peak of anion exchange chromatography,
containing the 20-, 25-, and 70-kDa proteins, will be useful for
serodiagnosis of fasciolosis without cross-reactivity with other
parasite infections such as hydatidosis.
Conclusion
Fractionation of F. hepatica ES-Ag by this procedure is a
fast, simple, and reproducible method for serodiagnosis of
human and sheep fasciolosis. The production of the recom-
binant forms of these immunogenic proteins could facili-
tate the development of more sensitive and specific detec-
tion methods.
Acknowledgments This study was supported by grant 24488 from the
Iran University of Medical Sciences (IUMS), Tehran, Iran. We thank
Professor Eshrat beigom Kia from the School of Public Health, Tehran
2964 Parasitol Res (2016) 115:2957–2965
University of Medical Sciences (Tehran, Iran) for providing strongyloi-
diasis sera and Professor AbdolFatah Sarafinejhad from the Noor Referral
Laboratory (Tehran, Iran) for providing us with fasciolosis patients’ sera.
References
Abath FG, Werkhauser RC (1996) The tegument of Schistosoma
mansoni: functional and immunological features. Parasite
Immunol 18:15–20
Allam AF, El-Agamy E-SI, Helmy MH (2002) Molecular and immuno-
logical characterization of Fasciola species. Br J Biomed Sci 59:
191–195
Ashrafi K, ValeroMA, PanovaM, PeriagoMV, Massoud J, Mas-Coma S
(2006) Phenotypic analysis of adults of Fasciola hepatica, Fasciola
gigantica and intermediate forms from the endemic region of Gilan,
Iran. Parasitol Int 55(4):249–260
Bossaert K, Farnir F, Leclipteux T, Protz M, Lonneux JF, Losson B (2000)
Humoral immune response in calves to single-dose, trickle and chal-
lenge infections with Fasciola hepatica. Vet Parasitol 87:103–123
Carnevale S, Rodriguez MI, Santillan G, Labbe JH, Cabrera MG,
Bellegarde EJ, Velasquez JN, Trgovcic JE, Guarnera EA (2001)
Immunodiagnosis of human fascioliasis by an enzyme-linked im-
munosorbent assay (ELISA) and a micro-ELISA. Clin Diagn Lab
Immunol 8:174–177
Cornelissen JB, Gaasenbeek CP, Boersma W, Borgsteede FH, van
Milligen FJ (1999) Use of a pre-selected epitope of cathepsin-L1
in a highly specific peptide-based immunoassay for the diagnosis of
Fasciola hepatica infections in cattle. Int J Parasitol 29:685–696
Cornelissen JB, Gaasenbeek CP, Borgsteede FH, Holland WG, Harmsen
MM, Boersma WJ (2001) Early immunodiagnosis of fasciolosis in
ruminants using recombinant Fasciola hepatica cathepsin L-like
protease. Int J Parasitol 31:728–737
Demerdash ZA, Diab TM, Aly IR, Mohamed SH,Mahmoud FS, Zoheiry
MK, Mansour WA, Attia ME, El-Bassiouny AE (2011) Diagnostic
efficacy of monoclonal antibody based sandwich enzyme linked
immunosorbent assay (ELISA) for detection of Fasciola gigantica
excretory/secretory antigens in both serum and stool. Parasit Vectors
4:176
Espino AM, Hillyer GV (2001) Identification of fatty acid molecules in a
Fasciola hepatica immunoprophylactic fatty acid-binding protein. J
Parasitol 87:426–428
Falak R, Sankian M, Noorbakhsh R, Tehrani M, Assarehzadegan MA,
Jabbari Azad F, Abojhasani A, Varasteh AR (2013) Identification
and characterisation of main allergic proteins in Vitis vinifera vitis.
Food Agric Immunol 24:255–268
Farghaly AM, Nada SM, EmamWA, Mattar MA, Mohamed SM, Sharaf
EM, Gamal RE (2009) Role of Fast-ELISA and Western blot in
diagnosis of human fasciolosis using crude adult worm and
excretory/secretory fasciola antigens. PUJ 2:55–65
Gonenc B, Sarimehmetoglu HO, Kara M, Kircali F (2004) Comparison
of crude and excretory/secretory antigens for the diagnosis of
Fasciola hepatica in sheep by Western blotting. Turk J Vet Anim
Sci 28:943–949
Hacariz O, Sayers G, Mulcahy G (2011) A preliminary study to under-
stand the effect of Fasciola hepatica tegument on naive macro-
phages and humoral responses in an ovine model. Vet Immunol
Immunopathol 139:245–249
Hillyer GV (1999) Immunodiagnosis of human and animal fasciolosis.
In: Dalton JP (ed) Fasciolosis. CABI Publishing, Wallingford, pp
435–447
Mas-Coma S, Bargues MD, Valero MA (2005) Fascioliasis and other
plant-borne trematode zoonoses. Int J Parasitol 35:1255–1278
McGonigle S, Dalton JP (1995) Isolation of Fasciola hepatica
haemoglobin. Parasitology 111:209–215
Meshgi B, Eslami A, Hemmatzadeh F (2008) Determination of somatic
and excretory-secretory antigens of Fasciola hepatica and Fasciola
gigantica using SDS-PAGE. Iranian J Vet Res 9:77–80
Mezo M, Gonzalez-Warleta M, Ubeira FM (2003) Optimized
serodiagnosis of sheep fascioliasis by Fast-D protein liquid chroma-
tography fractionation of Fasciola hepatica excretory-secretory an-
tigens. J Parasitol 89:843–849
Mohamed MM, Al-Sherbiny MM, Sharaf AA, Elmamlouk TH (2004)
Immunological identification of Fasciola hepatica antigens contain-
ing major human T-cell and B-cell epitopes. J Egypt Soc Parasitol
34:751–766
Morales A, Espino AM (2012) Evaluation and characterization of
Fasciola hepatica tegument protein extract for serodiagnosis of hu-
man fascioliasis. Clin Vaccine Immunol 19:1870–1878
Rivera-Marrero CA, Santiago N, Hillyer GV (1988) Evaluation of immu-
nodiagnostic antigens in the excretory-secretory products of
Fasciola hepatica. J Parasitol 74:646–652
Robinson MW, Menon R, Donnelly SM, Dalton JP, Ranganathan
S (2009) An integrated transcriptomics and proteomics anal-
ysis of the secretome of the helminth pathogen Fasciola
hepatica: proteins associated with invasion and infection of
the mammalian host. Mol Cell Proteomics 8:1891–1907
Rokni MB, Massoud J, O’Neill SM, Parkinson M, Dalton JP (2002)
Diagnosis of human fasciolosis in the Gilan province of Northern
Iran: application of cathepsin L-ELISA. Diagn Microbiol Infect Dis
44:175–179
Rokni MB, Baghernejhad A,MohebaliM, Kia EB (2004) Enzyme linked
immunotransfer blot analysis of somatic and excretory-secretory
antigens of Fasciola hepatica in diagnosis of human fasciolosis.
Iran J Publ Health 33:8–13
Rokni MB, Mirhendi H, Behnia M, Fasihi Harandi M, Jalalizand N
(2010) Molecular characterization of Fasciola hepatica isolates by
RAPD-PCR and ribosomal ITS1 sequencing. Iranian Red Crescent
Med J 12:27–32
Sampaio-Silva ML, Da Costa JM, Da Costa AM, Pires MA, Lopes SA,
Castro AM, Monjour L (1996) Antigenic components of excretory-
secretory products of adult Fasciola hepatica recognized in human
infections. Am J Trop Med Hyg 54:146–148
Sarkari B, Ghobakhloo N, Moshfea A, Eilami O (2012) Seroprevalence
of human fasciolosis in a new-emerging focus of fasciolosis in Yasuj
District, Southwest of Iran. Iran J Parasitol 7:15–20
Spithill TW, Smooker PM, Sexton JL, Bozas E, Morrison CA, Creaney J,
Parsons JCJP (1999) Development of vaccines against Fasciola
hepatica. In: Dalton JP (ed) Fasciolosis. CABI Publishing,
Wallingford, pp 377–401
Upadhyay AK, Kumar M (2002) SDS-PAGE analysis of Fasciola
gigantica antigen. J Immunol Immunopathol 4:91–92
Valero MA, Periago MV, Perez-Crespo I, Rodriguez E, Perteguer
MJ, Garate T, Gonzalez-Barbera EM, Mas-Coma S (2012)
Assessing the validity of an ELISA test for the serological
diagnosis of human fascioliasis in different epidemiological
situations. Trop Med Int Health 17:630–636
Yamano K, Goto A, Nakamura-Uchiyama F, Nawa Y, Hada N, Takeda T
(2009) Galbeta1-6Gal, antigenic epitope which accounts for sero-
logical cross-reaction in diagnosis of Echinococcus multilocularis
infection. Parasite Immunol 31:481–487
Parasitol Res (2016) 115:2957–2965 2965
